PPT-Journal Club - 25.04.19 ß blockers to prevent decompensation of cirrhosis in patients

PREDESCI a randomised doubleblind placebocontrolled multicentre trial Càndid Villanueva Agustín Albillos Joan Genescà Joan C Garcia Pagan José L Calleja Carles Aracil Rafael Bañares Rosa M Morillas María Poca . David W . Kabel. MD FACC. CHF-. Neurohormonal. Activation. NH activation is an acute adaptation that initially allows BP and cardiac output to be maintained. NH activation rapidly becomes detrimental. (Inderal, Inderal – LA generic). A CARDIOVASCULAR BETA BLOCKER. TEAM 2 MEMBERS:. . Stella . O. . Akpuaka. . . Bosede. . Adedire. Tamika Missouri. Amanda . Rothenbecker. What are Cardiovascular agents?. Best of ILC 2018. About these slides. These slides provide highlights of new data presented at the International Liver Congress 2018. Please feel free to use, adapt, and share these slides for your own personal use; however, please acknowledge EASL as the source. About these slides. These slides give a comprehensive overview of the EASL clinical practice guidelines on the management of decompensated cirrhosis. The guidelines were first presented at the International Liver Congress 2018 and are published in the Journal of Hepatology. A CARDIOVASCULAR BETA BLOCKER. TEAM 2 MEMBERS:. . Stella . O. . Akpuaka. . . Bosede. . Adedire. Tamika Missouri. Amanda . Rothenbecker. What are Cardiovascular agents?. Wide variety of drugs used for management and treatment of several different conditions of the heart and blood vessels.. Kings College Hospital London UK. . 20–50%. . <1.0%. . 2–3%. . 7–8%. . 3–5%. . 2–6% for HBeAg+. . 20–50%. <0.2%. . 8–10% for HBeAg-. HBV-related liver disease progression. varices. : update 2017 . DR. Supachoke Maspakorn . Overview . Variceal. bleeding is the most serious complication of . cirrhosis.. Up . to 50% mortality rate within 30 days of presentation. .. Isolate . Dr.AZDAKI. . (cardiologist).  Initial . monotherapy. is successful in many patients with mild primary hypertension (formerly called "essential" hypertension). . However, single-drug therapy is unlikely to attain goal blood pressure in patients whose blood pressures are more than 20/10 mmHg above goal. . Introduction Beta blockers have a long and well - established history of use for a variety of indications, and are one of the most widely used pharmacological agents for patients with cardiovascular Nicholas Lim, MD. Associate Professor of Medicine. Alaska Tribal Health Webinar Series. May 5. th. 2022. Disclosures. No Financial Relationships. No Discussion of Off-label Medication Use or Investigational Drugs. Trastuzumab-emtansine. : A . very. . nice. . poison. T-DM1 (. Trastuzumab. – . emtansine. ). Pre-Clinical and Early Clinical Development. May. , 2014. Overview. Anti HER2 therapy in . mBC. . –. 30.07.2020. “. Safety. . and. . feasibility. . of. transjugular . intrahepatic. . portosystemic. . shunt. in . elderly. . patients. . with. . liver. . cirrhosis. . and. . refractory. . Chris Kolkman. PrimaryOne. Health. Meet MM. Patient Background. MM is a 59-year-old Hispanic female who presents for a regular health checkup, accompanied by her daughter to help translate. . CC: “I would like to establish care here in the US and to have someone manage my diabetes and cirrhosis.”. Assist.lec. . . Shaymaa. . Hasan. Abbas. Ischemic Heart Disease. The major goals for the treatment of IHD are to:. • Prevent acute coronary syndromes and death . • Alleviate acute symptoms of myocardial ischemia.